Revcore for in Stent Thrombosis (Revit)
ClinicalTrials.gov NCT06394739
Research payments
$373,411
Through program year 2025, $373,411 in research payments was reported against Revcore for in Stent Thrombosis (Revit), across 126 payments.
- Paid by (largest first)
- Stryker Corporation; Inari Medical, Inc.
- ClinicalTrials.gov
- NCT06394739
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $281,590 | 117 |
| 2024 | Research | $91,821 | 9 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Abdullah Shaikh Pittsburgh, PA Named on 22 payments
- Ryan Cobb Philadelphia, PA Named on 20 payments
- Khanjan Nagarsheth Baltimore, MD Named on 17 payments
- Angelo Marino Hartford, CT Named on 16 payments
- Waseem Shami El Paso, TX Named on 12 payments
- Trevor Downing Asheville, NC Named on 11 payments
- Kyle Reynolds Washington, DC Named on 8 payments
- Karem Harth Cleveland, OH Named on 7 payments
- Steven Abramowitz Washington, DC Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.